Home / Latest Reports / Flow Cytometry Market

Flow Cytometry Market By Technology, Application, End User And Product - Global Industry Analysis And Forecast To 2023

Published On : August 2022 Pages : 190 Category: Biotechnology Report Code : HC05802

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Industry Outlook and Trend Analysis

The Flow Cytometry Market was worth USD 2.56 billion in 2017 and is expected to reach approximately USD 5.02 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 7.76% during the forecast period. Main drivers incorporate rising predominance of chronic diseases, which needs toxicity testing, for example, cancer tests and need accurate, rapid, and sensitive prognosis procedures for the validation of the disease. Developing awareness level among patients and healthcare experts and high level of healthcare expenses are significant drivers for flow cytometry industry development. Besides, related benefits of cell-based tests, for example, high sensitivity & reproductively, simple usability, and progression in reagents and software used for the analysis are different components anticipated that would drive the development.

Technology Outlook and Trend Analysis

Cell-based flow cytometry commanded the general market. Expanding demand for early analysis and rising awareness relating to related advantages with cell-based assays are the elements ascribing to its predominance over the conjecture time frame. Cell-based flow cytometry has broad applications in different research fields. These measures are used as a part of drug discovery for the physiological significance of the outcomes.

Product Outlook and Trend Analysis

The instrument section ruled the market in 2017 attributable to more penetration combined with benefits, for example, cost-effective nature, user-friendliness, and accurate result. Reagents and consumables, inferable from their expanded use in cancer diagnostics are foreseen to exhibit lucrative development. The instruments used for flow cytometry are cell sorters, cell analysers, and sample preparation devices, for example, stages for cell investigation and replaceable parts like lasers, filters, and detectors.

Application Outlook and Trend Analysis

Stream cytometry has applications in research, industrial sectors, and clinical diagnosis. Research fragment ruled in 2017 inferable from an expanding R&D relating to cancer and different infectious illnesses. Flow cytometry additionally has applications in different businesses, for example, plant tissue culture and food microbiology. Clinical finding is anticipated to be the quickest developing application portion over the forecast period.

End User Outlook and Trend Analysis

The commercial organization fragment held the biggest income share inferable from wide applications crosswise over different verticals, for example, blood banks, food microbiology, and plant cell culture. The advent of multiplex reagents and probes for particular applications in diagnostics and drug discovery is anticipated to serve this vertical with development opportunities by taking into account the clients in research and small peripheral laboratories.

Regional Outlook and Trend Analysis

North America ruled the general stream cytometry Industry in 2017 because of the existence of strong government changes for the improvement of advanced technologies for molecular diagnostics. Also, availability of experts and higher awareness level are a portion of the components foreseen to help the local market growth. Asia Pacific district is foreseen to reflect lucrative development in the coming years attributable to expanding steady government financing for biotech industry advancement.

Competitive Insights

The leading players in the market are Luminex Corporation, Becton Dickinson, Apogee Flow Systems Ltd, GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, Stratedigm Inc, Bio-Rad Laboratories, Beckman Coulter, Sysmex Corporation and Merck & Co. The market is competitive in nature as major players are engaged in constant product enhancement and partnership alliances to aid market penetration. A vast number of outsourcing service providers is anticipated to increase industry competition in the near future.

The Flow Cytometry Market is segmented as follows-

By Technology:

  • Bead based
  • Cell based

By Product:

  • Reagent & consumables
  • Software
  • Instruments
  • Accessories
  • services

By Application:

  • Industrial
  • Research
  • Clinical

By End User:

  • Hospitals
  • Clinical testing labs
  • Commercial organizations
  • Academic institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Flow Cytometry Market, By Technology

5.1.       Introduction

5.2.       Global Flow Cytometry Sales, Revenue and Market Share by Technology (2017-2027)

5.2.1.  Global Flow Cytometry Sales and Sales Share by Technology (2017-2027)

5.2.2.  Global Flow Cytometry Revenue and Revenue Share by Technology (2017-2027)

5.3.       Cell based

5.3.1.  Global Cell based Sales and Growth Rate (2017-2027)

5.4.       Bead based

5.4.1.  Global Internal Sales and Growth Rate (2017-2027)

6.       Flow Cytometry Market, By Product

6.1.       Introduction

6.2.       Global Flow Cytometry Sales, Revenue and Market Share by Product (2017-2027)

6.2.1.  Global Flow Cytometry Sales and Sales Share by Product (2017-2027)

6.2.2.  Global Flow Cytometry Revenue and Revenue Share by Product (2017-2027)

6.3.       Instruments

6.3.1.  Global Instruments Sales and Growth Rate (2017-2027)

6.4.       Reagent & consumables

6.4.1.  Global Reagent & consumables Sales and Growth Rate (2017-2027)

6.5.       Software

6.5.1.  Global Software Sales and Growth Rate (2017-2027)

6.6.       Accessories

6.6.1.  Global Accessories Sales and Growth Rate (2017-2027)

6.7.       Services

6.7.1.  Global Services Sales and Growth Rate (2017-2027)

7.       Flow Cytometry Market, By Application

7.1.       Introduction

7.2.       Global Flow Cytometry Sales, Revenue and Market Share by Application (2017-2027)

7.2.1.  Global Flow Cytometry Sales and Sales Share by Application (2017-2027)

7.2.2.  Global Flow Cytometry Revenue and Revenue Share by Application (2017-2027)

7.3.       Research

7.3.1.  Global Research Sales and Growth Rate (2017-2027)

7.4.       Industrial

7.4.1.  Global Industrial Sales and Growth Rate (2017-2027)

7.5.       Clinical

7.5.1.  Global Clinical Sales and Growth Rate (2017-2027)

8.       Flow Cytometry Market, By End User

8.1.       Introduction

8.2.       Global Flow Cytometry Sales, Revenue and Market Share by End User (2017-2027)

8.2.1.  Global Flow Cytometry Sales and Sales Share by End User (2017-2027)

8.2.2.  Global Flow Cytometry Revenue and Revenue Share by End User (2017-2027)

8.3.       Commercial organizations

8.3.1.  Global Commercial organizations Sales and Growth Rate (2017-2027)

8.4.       Hospitals

8.4.1.  Global Hospitals Sales and Growth Rate (2017-2027)

8.5.       Academic institutes

8.5.1.  Global Academic institutes Sales and Growth Rate (2017-2027)

8.6.       Clinical testing labs

8.6.1.  Global Clinical testing labs Sales and Growth Rate (2017-2027)

9.       Flow Cytometry Market, By Region

9.1.       Introduction

9.2.       Global Flow Cytometry Sales, Revenue and Market Share by Regions

9.2.1.  Global Flow Cytometry Sales by Regions (2017-2027)

9.2.2.  Global Flow Cytometry Revenue by Regions (2017-2027)

9.3.       North America Flow Cytometry by Countries

9.3.1.  North America Flow Cytometry Sales and Growth Rate (2017-2027)

9.3.2.  North America Flow Cytometry Revenue and Growth Rate (2017-2027)

9.3.3.  North America Flow Cytometry Sales by Countries (2017-2027)

9.3.4.  North America Flow Cytometry Revenue (Million USD) by Countries (2017-2027)

9.3.5.  U.S.

9.3.5.1.    United States Flow Cytometry Sales and Growth Rate (2017-2027)

9.3.5.2.    United States Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.6.  Canada

9.3.6.1.    Canada Flow Cytometry Sales and Growth Rate (2017-2027)

9.3.6.2.    Canada Flow Cytometry Sales (Millions USD) and Growth Rate (2017-2027)

9.3.7.  Mexico

9.3.7.1.    Mexico Flow Cytometry Sales and Growth Rate (2017-2027)

9.3.7.2.    Mexico Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.       Europe Flow Cytometry by Countries

9.4.1.  Europe Flow Cytometry Sales and Growth Rate (2017-2027)

9.4.2.  Europe Flow Cytometry Revenue and Growth Rate (2017-2027)

9.4.3.  Europe Flow Cytometry Sales by Countries (2017-2027)

9.4.4.  Europe Flow Cytometry Revenue (Million USD) by Countries (2017-2027)

9.4.5.  Germany

9.4.5.1.    Germany Flow Cytometry Sales and Growth Rate (2017-2027)

9.4.5.2.    Germany Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  UK

9.4.6.1.    UK Flow Cytometry Sales and Growth Rate (2017-2027)

9.4.6.2.    UK Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  France

9.4.7.1.    France Flow Cytometry Sales and Growth Rate (2017-2027)

9.4.7.2.    France Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Russia

9.4.8.1.    Russia Flow Cytometry Sales and Growth Rate (2017-2027)

9.4.8.2.    Russia Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.9.  Italy

9.4.9.1.    Italy Flow Cytometry Sales and Growth Rate (2017-2027)

9.4.9.2.    Italy Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.10.      Rest of Europe

9.4.10.1. Rest of Europe Flow Cytometry Sales and Growth Rate (2017-2027)

9.4.10.2. Rest of Europe Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.       Asia-Pacific

9.5.1.  Asia-Pacific Flow Cytometry Sales and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Flow Cytometry Revenue and Growth Rate (2017-2027)

9.5.3.  Asia-Pacific Flow Cytometry Sales by Countries (2017-2027)

9.5.4.  Asia-Pacific Flow Cytometry Revenue (Million USD) by Countries (2017-2027)

9.5.5.  China

9.5.5.1.    China Flow Cytometry Sales and Growth Rate (2017-2027)

9.5.5.2.    China Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  Japan

9.5.6.1.    Japan Flow Cytometry Sales and Growth Rate (2017-2027)

9.5.6.2.    Japan Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.3.     

9.5.7.  Korea

9.5.7.1.    Korea Flow Cytometry Sales and Growth Rate (2017-2027)

9.5.7.2.    Korea Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  India

9.5.8.1.    India Flow Cytometry Sales and Growth Rate (2017-2027)

9.5.8.2.    India Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.9.  Southeast Asia

9.5.9.1.    Southeast Asia Flow Cytometry Sales and Growth Rate (2017-2027)

9.5.9.2.    Southeast Asia Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.10.      Rest of Asia-Pacific

9.5.10.1. Rest of Asia-Pacific Flow Cytometry Sales and Growth Rate (2017-2027)

9.5.10.2. Rest of Asia-Pacific Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.       South America

9.6.1.  South America Flow Cytometry Sales and Growth Rate (2017-2027)

9.6.2.  South America Flow Cytometry Revenue and Growth Rate (2017-2027)

9.6.3.  South America Flow Cytometry Sales by Countries (2017-2027)

9.6.4.  South America Flow Cytometry Revenue (Million USD) by Countries (2017-2027)

9.6.5.  Brazil

9.6.5.1.    Brazil Flow Cytometry Sales and Growth Rate (2017-2027)

9.6.5.2.    Brazil Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Argentina

9.6.6.1.    Argentina Flow Cytometry Sales and Growth Rate (2017-2027)

9.6.6.2.    Argentina Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.7.  Columbia

9.6.7.1.    Columbia Flow Cytometry Sales and Growth Rate (2017-2027)

9.6.7.2.    Columbia Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.8.  Rest of South America

9.6.8.1.    Rest of South America Flow Cytometry Sales and Growth Rate (2017-2027)

9.6.8.2.    Rest of South America Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.       Middle East and Africa

9.7.1.  Middle East and Africa Flow Cytometry Sales and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Flow Cytometry Revenue and Growth Rate (2017-2027)

9.7.3.  Middle East and Africa Flow Cytometry Sales by Countries (2017-2027)

9.7.4.  Middle East and Africa Flow Cytometry Revenue (Million USD) by Countries (2017-2027)

9.7.5.  Saudi Arabia

9.7.5.1.    Saudi Arabia Flow Cytometry Sales and Growth Rate (2017-2027)

9.7.5.2.    Saudi Arabia Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  United Arab Emirates

9.7.6.1.    United Arab Emirates Flow Cytometry Sales and Growth Rate (2017-2027)

9.7.6.2.    United Arab Emirates Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  Egypt

9.7.7.1.    Egypt Flow Cytometry Sales and Growth Rate (2017-2027)

9.7.7.2.    Egypt Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Nigeria

9.7.8.1.    Nigeria Flow Cytometry Sales and Growth Rate (2017-2027)

9.7.8.2.    Nigeria Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  South Africa

9.7.9.1.    South Africa Flow Cytometry Sales and Growth Rate (2017-2027)

9.7.9.2.    South Africa Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.10.      Rest of Middle East and Africa

9.7.10.1. Rest of Middle East and Africa Flow Cytometry Sales and Growth Rate (2017-2027)

9.7.10.2. Rest of Middle East and Africa Flow Cytometry Revenue (Millions USD) and Growth Rate (2017-2027)

10.   Company Profiles

10.1.    Danaher Corporation

10.1.1.      Business Overview

10.1.2.      Product Portfolio

10.1.3.      Strategic Developments

10.1.4.      Sales, Revenue and Market Share

10.2.    Becton, Dickinson and Company

10.2.1.      Business Overview

10.2.2.      Product Portfolio

10.2.3.      Strategic Developments

10.2.4.      Sales, Revenue and Market Share

10.3.    Sysmex Corporation

10.3.1.      Business Overview

10.3.2.      Product Portfolio

10.3.3.      Strategic Developments

10.3.4.      Sales, Revenue and Market Share

10.4.    Agilent Technologies

10.4.1.      Business Overview

10.4.2.      Product Portfolio

10.4.3.      Strategic Developments

10.4.4.      Sales, Revenue and Market Share

10.5.    Merck & Co., Inc.

10.5.1.      Business Overview

10.5.2.      Product Portfolio

10.5.3.      Strategic Developments

10.5.4.      Sales, Revenue and Market Share

10.6.    Apogee Flow Systems

10.6.1.      Business Overview

10.6.2.      Product Portfolio

10.6.3.      Strategic Developments

10.6.4.      Sales, Revenue and Market Share

10.7.     Bio-Rad Laboratories

10.7.1.      Business Overview

10.7.2.      Product Portfolio

10.7.3.      Strategic Developments

10.7.4.      Sales, Revenue and Market Share

10.8.    Thermo Fisher Scientific

10.8.1.      Business Overview

10.8.2.      Product Portfolio

10.8.3.      Strategic Developments

10.8.4.      Sales, Revenue and Market Share

10.9.    Stratedigm

10.9.1.      Business Overview

10.9.2.      Product Portfolio

10.9.3.      Strategic Developments

10.9.4.      Sales, Revenue and Market Share

10.10.Luminex Corporation

10.10.1.  Business Overview

10.10.2.  Product Portfolio

10.10.3.  Strategic Developments

10.10.4.  Sales, Revenue and Market Share

11.   Global Flow Cytometry Market Competition, by Manufacturer

11.1.    Global Flow Cytometry Sales and Market Share by Manufacturer (2017-2017)

11.2.    Global Flow Cytometry Revenue and Market Share by Manufacturer (2017-2017)

11.3.    Global Flow Cytometry Price by Manufacturer (2017-2017)

11.4.    Top 5 Flow Cytometry Manufacturer Market Share

11.5.    Market Competition Trend

12.   Flow Cytometry Market Forecast (2027-2023)

12.1.    Global Flow Cytometry Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

12.2.    Flow Cytometry Market Forecast by Regions (2027-2023)

12.2.1.      North America Flow Cytometry Market Forecast (2027-2023)

12.2.1.1. United States Flow Cytometry Market Forecast (2027-2023)

12.2.1.2. Canada Flow Cytometry Market Forecast (2027-2023)

12.2.1.3. Mexico Flow Cytometry Market Forecast (2027-2023)

12.2.2.      Europe Flow Cytometry Market Forecast (2027-2023)

12.2.2.1. Germany Flow Cytometry Market Forecast (2027-2023)

12.2.2.2. United Kingdom Flow Cytometrys Market Forecast (2027-2023)

12.2.2.3. France Flow Cytometry Market Forecast (2027-2023)

12.2.2.4. Russia Flow Cytometry Market Forecast (2027-2023)

12.2.2.5. Italy Flow Cytometry Market Forecast (2027-2023)

12.2.2.6. Rest of the Europe Flow Cytometry Market Forecast (2027-2023)

12.2.3.      Asia-Pacific Flow Cytometry Market Forecast (2027-2023)

12.2.3.1. China Flow Cytometry Market Forecast (2027-2023)

12.2.3.2. Japan Flow Cytometry Market Forecast (2027-2023)

12.2.3.3. Korea Flow Cytometry Market Forecast (2027-2023)

12.2.3.4. India Flow Cytometry Market Forecast (2027-2023)

12.2.3.5. Southeast Asia Flow Cytometry Market Forecast (2027-2023)

12.2.3.6. Rest of Asia-Pacific Flow Cytometry Market Forecast (2027-2023)

12.2.4.      South America Flow Cytometry Market Forecast (2027-2023)

12.2.4.1. Brazil Flow Cytometry Market Forecast (2027-2023)

12.2.4.2. Argentina Flow Cytometry Market Forecast (2027-2023)

12.2.4.3. Columbia Flow Cytometry Market Forecast (2027-2023)

12.2.4.4. Rest of South America Flow Cytometry Market Forecast (2027-2023)

12.2.5.      Middle East and Africa Flow Cytometry Market Forecast (2027-2023)

12.2.5.1. Saudi Arabia Flow Cytometry Market Forecast (2027-2023)

12.2.5.2. UAE Flow Cytometry Market Forecast (2027-2023)

12.2.5.3. Egypt Flow Cytometry Market Forecast (2027-2023)

12.2.5.4. Nigeria Flow Cytometry Market Forecast (2027-2023)

12.2.5.5. South Africa Flow Cytometry Market Forecast (2027-2023)

12.2.5.6. Rest of MEA Flow Cytometry Market Forecast (2027-2023)

12.3.    Flow Cytometry Market Forecast by Technology (2027-2023)

12.3.1.      Global Flow Cytometry Sales Forecast by Technology (2027-2023)

12.3.2.      Global Flow Cytometry Sales Market Share Forecast by Technology (2027-2023)

12.4.    Flow Cytometry Market Forecast by Product (2027-2023)

12.4.1.      Global Flow Cytometry Sales Forecast by Product (2027-2023)

12.4.2.      Global Flow Cytometry Sales Market Share Forecast by Product (2027-2023)

12.5.    Flow Cytometry Market Forecast by Application (2027-2023)

12.5.1.      Global Flow Cytometry Sales Forecast by Application (2027-2023)

12.5.2.      Global Flow Cytometry Sales Market Share Forecast by Application (2027-2023)

12.6.      Flow Cytometry Market Forecast by End User (2027-2023)

12.6.1.      Global Flow Cytometry Sales Forecast by End User (2027-2023)

12.6.2.      Global Flow Cytometry Sales Market Share Forecast by End User (2027-2023)

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Flow Cytometry Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample